Bret Christensen is the President and CEO of DermTech, a company pioneering non-invasive skin genomics. With a robust background in scaling diagnostic companies, Christensen brings a wealth of experience to DermTech.
Who is the CEO of DermTech?
Before joining DermTech as President and CEO, Bret Christensen built a distinguished career in the healthcare and diagnostics industry. He served as Chief Commercial Officer at Insulet, where he significantly increased sales from $367 million to $1.1 billion. Prior to that, he held key roles at Myriad Genetics, Hologic, and Cytyc Corporation, demonstrating his expertise in scaling diagnostic companies and securing reimbursement.
Work History
Bret Christensen's extensive work history showcases his expertise and leadership in the healthcare and diagnostics industry. Here are the key positions he has held:
- DermTech - President and CEO (2023-05-01 to Present)
- Axena Health - Board Member (2023-02-01 to Present)
- Insulet Corporation - Chief Commercial Officer (2017-05-01 to 2023-05-01)
- Myriad Genetics - General Manager, Preventive Care Business Unit (2013-08-01 to 2017-05-01)
- Hologic - Vice President of Sales and Marketing (2012-09-01 to 2013-08-01)
- Hologic - Vice President of Surgical Sales - North America (2009-12-01 to 2012-12-01)
- Hologic - Regional Business Director (2003-03-01 to 2009-12-01)
Education History
Bret Christensen's educational journey is marked by his pursuit of advanced business knowledge. He earned his MBA from the University of Utah's David Eccles School of Business, where he studied from January 1998 to January 2000. Additionally, he attended The University of Chicago Booth School of Business for a brief period in January 2007, further enhancing his expertise in business management. This solid educational foundation has undoubtedly contributed to his successful career in the healthcare and diagnostics industry.
When did Bret Christensen join DermTech?
Joining DermTech as President and CEO on May 1, 2023, Bret Christensen has quickly become a pivotal figure in the company's leadership. With his extensive background in scaling diagnostic companies, Christensen's appointment marks a significant step forward for DermTech.
As of now, he has been with the company for several months, bringing his expertise and vision to the forefront of DermTech's mission to innovate in melanoma care.